IL17A and autism: Previous studies indicated that prenatal MIA could increase the levels of interleukin-17A (IL-17A), which initiated immune-primed phenotypes in offspring that exhibited autism-like phenotypes and increased susceptibility to develop intestinal inflammation later in life [38,39].